Schizophrenia is a complex and chronic brain disorder affecting approximately 2.8 million adults in the US. Dr. Gustavo Alva, Medical Director at ATP Clinical Research (Gus Alva MD – ATP Clinical Research) and Patrick, an adult living with schizophrenia have information about a new FDA approved treatment.
Learn More About This New FDA Approved Treatment for Schizophrenia
WEEKLY EPISODE SUMMARIES
latest TV episodes
Travel: America’s National World War II Museum-Expressions of America
America's National World War II Museum unveiled its first of
The Warning Signs of Chronic Kidney Disease and Treatment Options
Kathleen Belmonte, Chief Nursing Officer at Fresenius Medical Care North
Information About A New Technology That Allows Clinicians to Better Connect their Valuable Patients
Kenneth Harper, Vice President, General Manager of Ambient Clinical Intelligence
latest RADIO episodes
